The U.S. Court of Appeals for the Third Circuit in a split decision today affirmed a district court ruling granting summary ...
A federal appeals court rejected challenges by major pharmaceutical companies to Medicare drug price negotiations.
It was another swing and a miss for the biopharma industry on Thursday, when a federal appeals court in Philadelphia ...
In Bristol-Myers Squibb Co. v. Teva Pharmaceuticals USA, Inc., the Federal Circuit affirmed the district court’s finding that BMS’s Baraclude® patent is invalid as obvious. In so doing, the court gave ...
Philadelphia, PA – A federal appeals court has upheld the Biden administration’s authority to negotiate Medicare drug prices, ...
On December 5, 2017, the Federal Circuit heard oral argument in Momenta Pharmaceuticals, Inc. v. Bristol-Myers Squibb Company, 17-1694. Momenta is appealing a PTAB decision upholding the validity of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback